The only commercialized pdt poh has had is tpm diclofenac. But with the sales/ distribution performance so far Novartis must be wondering what they were thinking . Perhaps Novartis felt/ were obligated to take it to market . Perhaps Mylan are less obliging.
Tpm dapto may do what it 'sais on the tin' but coys have more acceptable reasons for not moving forward .
Share Price After Award Decision, page-135
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add POH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| POH (ASX) Chart |
Day chart unavailable
